Skip to search formSkip to main contentSkip to account menu

Combivent Respimat

Known as: Respimat, Combivent 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Albuterol / Ipratropium

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Comparative Effectiveness of Two Tiotropium Formulations: A Retrospective Cohort Study
Abstract The effectiveness of the tiotropium Respimat® formulation in routine clinical practice is still an open issue due to… 
2018
2018
Клиническая и фармакоэкономическая оценка применения комбинации тиотропия бромида и олодатерола у пациентов с хронической обструктивной болезнью легких
The paper is devoted to the problem of clinical efficacy and pharmacoeconomic evaluation of Spiolto Respimat. The results of… 
2016
2016
Efficacité de l’olodatérol Respimat® (Striverdi Respimat®) sur la fonction respiratoire des patients BPCO : résultats de 2 études de 48 semaines
2015
2015
Neue ESC-Leitlinie berücksichtigt NOAK
Anlässlich der europäischen Zulassung von Tiotropium/Olodaterol (Spiolto®) legte Prof. Dr. Klaus Rabe, Kiel, dar, dass die… 
2004
2004
Long-Term Efficacy and Safety of Ipratropium Bromide plus Fenoterol via Respimat® Soft Mist™ Inhaler (SMI) versus a Pressurised Metered-Dose Inhaler in Asthma
ObjectiveRespimat® Soft Mist™ Inhaler (SMI) is a novel, propellant-free device that significantly increases lung deposition… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)